Merck & Co., Inc. (MRK)

Merck & Co. Operating Expense Breakdown

Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018
Research and Development	24.76B	15.79B	16.49B	18.12B	17.57B	17.94B	22.98B	20.43B
Research and Development Growth	40.94%	-11.99%	-28.26%	-11.31%	-41.92%	-41.25%	-6.88%	-20.74%
Selling, General, and Administrative	10.88B	10.73B	10.70B	10.80B	10.89B	10.82B	10.76B	10.55B
Selling, General, and Administrative Growth	-0.06%	-0.79%	-0.55%	2.38%	3.60%	2.98%	3.56%	1.51%
Restructuring	1.02B	889.00M	727.00M	736.00M	256.00M	310.00M	514.00M	584.00M
Restructuring Growth	296.48%	186.77%	41.44%	26.03%	-60.92%	-48.25%	30.79%	61.77%
Other Expenses	325.00M	152.00M	-154.00M	-78.00M	-29.00M	-27.00M	-75.00M	213.00M
Other Expenses Growth	-	-	-	-	-	-	-	-65.37%

Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.